Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review

被引:15
作者
Franchini, Massimo [1 ]
Cappello, Emiliano [2 ]
Valdiserra, Giulia [2 ]
Bonaso, Marco [2 ]
Moretti, Ugo [3 ]
Focosi, Daniele [4 ]
Tuccori, Marco [2 ,5 ]
机构
[1] Carlo Poma Hosp, Div Transfus Med, Mantua, Italy
[2] Univ Pisa, Dept Clin & Expt Med, Unit Pharmacol & Pharmacovigilance, Pisa, Italy
[3] Univ Verona, Dept Diagnost & Publ Hlth, Sect Pharmacol, Verona, Italy
[4] Pisa Univ Hosp, North Western Tuscany Blood Bank, Pisa, Italy
[5] Univ Hosp Pisa, Unit Adverse Drug React Monitoring, Pisa, Italy
关键词
acquired haemophilia A autoimmunity; COVID-19; mRNA vaccines; BNT162b2; mRNA-1273; ANTIBODIES; INHIBITORS;
D O I
10.1055/s-0042-1754389
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acquired hemophilia A (AHA), a rare but life-threatening disorder, most commonly occurs in older people and during pregnancy. During the coronavirus disease 2019 (COVID-19) vaccination campaign, an unexpected number of newly diagnosed AHA patients have been identified in clinical practice that were temporally related to COVID-19 vaccination. We present the result of a signal detection analysis aimed at exploring a possible association between COVID-19 immunization and occurrence of AHA. A disproportionality analysis on the World Health Organization (WHO) database was performed to investigate the presence of a signal of risk for AHA associated with COVID-19 vaccines. Reports of AHA associated with any COVID-19 vaccine included in the WHO database were then integrated with those available on the Food and Drug Administration Vaccine Adverse Events Reporting System and those published in the medical literature. The WHO database included 146 reports of AHA. The information component (IC) was significant for the association of AHA with all COVID-19 vaccines (IC025: 1.1) and with the vaccine product BNT162b2 (IC025: 1.6). After duplicate exclusion, 96 unique cases of AHA following COVID-19 vaccines have been reviewed. Median time to diagnosis was 18 days and 40% of cases documented the occurrence after the second dose. Overall, in 57% of the investigated cases, a preexisting condition predisposing to AHA was excluded. About 22% of cases occurred in subjects with age <= 65 years and there was no case associated with pregnancy. Mortality was 11%. Although we cannot exclude that the unexpected frequency of AHA diagnosis can be explained by a detection bias, the signal for COVID-19 vaccine-related AHA is robust and deserves further investigations.
引用
收藏
页码:15 / 26
页数:12
相关论文
共 40 条
[1]   Acquired Hemophilia A Post-COVID-19 Vaccination: A Case Report and Review [J].
Al Hennawi, Hussam ;
Al Masri, Mohammad K. ;
Bakir, Mohamad ;
Barazi, Mohidin ;
Jazaeri, Feras ;
Almasri, Talal N. ;
Shoura, Sami J. ;
Barakeh, Abdul Rahman R. ;
Taftafa, Abdulrahman ;
Khan, Muhammad K. ;
Zaleski, Henry, I .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
[2]   NATURAL ANTIBODIES TO FACTOR-VIII (ANTI-HEMOPHILIC FACTOR) IN HEALTHY-INDIVIDUALS [J].
ALGIMAN, M ;
DIETRICH, G ;
NYDEGGER, UE ;
BOIELDIEU, D ;
SULTAN, Y ;
KAZATCHKINE, MD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :3795-3799
[3]  
[Anonymous], 2019, VACC ADV EV REP SYST
[4]   A Bayesian neural network method for adverse drug reaction signal generation [J].
Bate, A ;
Lindquist, M ;
Edwards, IR ;
Olsson, S ;
Orre, R ;
Lansner, A ;
De Freitas, RM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (04) :315-321
[5]   Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations [J].
Caster, Ola ;
Aoki, Yasunori ;
Gattepaille, Lucie M. ;
Grundmark, Birgitta .
DRUG SAFETY, 2020, 43 (05) :479-487
[6]   The statistical risk of diagnosing coincidental acquired hemophilia A following anti-SARS-CoV-2 vaccination [J].
Cittone, Micol G. ;
Battegay, Raphael ;
Condoluci, Adalgisa ;
Terzi di Bergamo, Lodovico ;
Fernandes, Eliana ;
Galfetti, Elena ;
Noseda, Roberta ;
Leuppi-Taegtmeyer, Anne ;
Drexler, Beatrice ;
Ceschi, Alessandro ;
Tsakiris, Dimitrios A. ;
Berger, Christoph T. ;
Favre, Genevieve ;
Martin, Thomas ;
Korte, Wolfgang ;
Graf, Lukas ;
Martinez, Maria ;
Gerber, Bernhard .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (09) :2360-2362
[7]   Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation [J].
Collins, Peter W. ;
Hirsch, Sybil ;
Baglin, Trevor P. ;
Dolan, Gerard ;
Hanley, John ;
Makris, Michael ;
Keeling, David M. ;
Liesner, Ri ;
Brown, Simon A. ;
Hay, Charles R. M. .
BLOOD, 2007, 109 (05) :1870-1877
[8]   Acquired haemophilia A: Italian Consensus Recommendations on diagnosis, general management and treatment of bleeding [J].
Coppola, Antonio ;
Franchini, Massimo ;
Tripodi, Armando ;
Santoro, Rita C. ;
Castaman, Giancarlo ;
Marino, Renato ;
Zanon, Ezio ;
Santoro, Cristina ;
Rivolta, Gianna F. ;
Contino, Laura ;
De Cristfaro, Raimondo ;
Molinari, Angelo C. ;
Gressel, Paolo ;
Rocino, Angiola .
BLOOD TRANSFUSION, 2022, 20 (03) :245-262
[9]   Acquired Inhibitors of Coagulation Factors: Part I-Acquired Hemophilia A [J].
Coppola, Antonio ;
Favaloro, Emmanuel J. ;
Tufano, Antonella ;
Di Minno, Matteo Nicola Dario ;
Cerbone, Anna Maria ;
Franchini, Massimo .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2012, 38 (05) :433-446
[10]  
European Medicines Agency, ASTRAZENECAS COVID 1